The global medical exoskeleton market size is expected to reach USD 6.25 Billion at a steady revenue CAGR of 45.0% in 2030, according to the latest analysis by Emergen Research. Large investments in the development of exoskeleton technology is driving revenue growth of the medical exoskeletons market. For instance, exoskeleton developer Wandercraft secured USD 45 million in Series C funding. Wandercraft is situated in Paris. The cash will be used by the business to develop and market a personal exoskeleton for use in the outdoors and at home, as well as hasten the introduction of Wandercraft's Atalante rehabilitation exoskeleton in the U.S. Atalante is a lower-body exoskeleton that can balance itself and mimics how individuals walk. In 2017, the business started the exoskeleton's clinical trials. In 2019, many drugs received Conformité Européene (CE) marking. With the use of the company's hands-free function, the exoskeleton is made to enable the wearer to move their upper body and torso without restriction. Exoskeletons are used to help physical therapy patients move more quickly and comfortably. https://www.emergenresearch.com/industry-report/medical-exoskeleton-market